OVA-Q7 Peptide, pQ7, SIINFEQL, OVA (257-264) Variant is a modified ovalbumin epitope used to probe MHC anchor residue tolerance. Substitution at the C-terminal position fine-tunes peptide–MHC stability and TCR engagement. Researchers employ it to dissect subtle sequence effects on antigen potency. The peptide aids comparative immunological profiling against canonical SIINFEKL.
CAT No: O05023
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. Emu oil in combination with other active ingredients for treating skin imperfections
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.